Clinical Trials

    A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (IDeate-Lung02)

    Investigator: Jun Zhang

    Study Coordinator: Johnnie Young

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06203210

    Phone: 346.238.5839

    Protocol Number: PRO00038231

    Description


    This study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung cancer (SCLC).